Surgical and Patient-Reported Outcomes of Delayed Anastomotic Urethroplasty for Male Pelvic Fracture Urethral Injury at a Japanese Referral Center.
Akio HoriguchiMasayuki ShinchiKenichiro OjimaYusuke HiranoKeiichi ItoRyuichi AzumaPublished in: Journal of clinical medicine (2022)
We aimed to assess the surgical and patient-reported outcomes of delayed anastomotic urethroplasty (DAU) for pelvic fracture urethral injury (PFUI). We included 211 male patients who underwent DAU for PFUI. DAU success was considered when the urethral lumen was sufficiently large for the passage of a flexible cystoscope, without additional treatment required. The patients completed the lower urinary tract symptoms (LUTS)-related quality of life (QOL) questionnaire (scores: 0, not at all; 1, a little; 2, somewhat; 3, a lot), EuroQol-5 dimensions (EQ-5D), and EQ-5D visual analog scale (EQ-VAS). Postoperative overall satisfaction was evaluated using the following responses: "very satisfied," "satisfied," "unsatisfied," or "very unsatisfied." DAU was successful in 95.3% cases, with a median postoperative follow-up duration of 48 months. Multivariate logistic regression analysis revealed that "greater blood loss" was an independent predictor of failed urethroplasty. Questionnaire responses were obtained from 80.1% patients. The mean LUTS-related QOL, EQ-5D score and EQ-VAS improved significantly from 2.8, 0.63 and 54.4 at baseline to 0.9, 0.81 and 76.6 postoperatively ( p < 0.0001 for all parameters). Moreover, 35.5% and 59.2% of the patients responded being "satisfied" and "very satisfied," respectively, with their DAU outcomes. DAU not only had a high surgical success rate, but also a significant beneficial effect on both LUTS-related QOL and overall health-related QOL.
Keyphrases
- patient reported outcomes
- end stage renal disease
- lower urinary tract symptoms
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- rectal cancer
- metabolic syndrome
- benign prostatic hyperplasia
- cross sectional
- patient reported
- single cell
- insulin resistance
- smoking cessation
- data analysis
- urinary incontinence